Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

199
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
What is Metabolism?00:52

What is Metabolism?

131.4K
Overview
131.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

271
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

531
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
531
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

889
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
889

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safeguarding the Future of Pediatric Nurse Practitioner.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·2026
Same author

Tidbits on Billing in Primary and Acute Care.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·2025
Same author

Painting the Real Picture: A Primer of Legal Issues.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·2025
Same author

Idiopathic anaphylaxis: What you do not know may hurt you.

Journal of the American Association of Nurse Practitioners·2019
Same author

An adolescent male with a nonhealing leg ulcer: A case of granulomatosis with polyangiitis.

The Nurse practitioner·2018
Same author

Diagnosis and primary care management of focal segmental glomerulosclerosis in children.

The Nurse practitioner·2018

Related Experiment Video

Updated: Jan 23, 2026

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
10:31

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment

Published on: April 20, 2018

11.1K

Pediatric metabolic syndrome.

Abigail Felix1, Rita Marie John

  • 1Abigail Felix is an NP student at Columbia University School of Nursing, New York, N.Y. Rita Marie John is a special lecturer at Columbia University School of Nursing, New York, N.Y.

The Nurse Practitioner
|June 19, 2019
PubMed
Summary

Pediatric metabolic syndrome is rising, but proper management can prevent chronic diseases. This overview covers guidelines, risk factors, and clinical implications for childhood metabolic syndrome.

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.4K
Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.4K

Related Experiment Videos

Last Updated: Jan 23, 2026

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
10:31

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment

Published on: April 20, 2018

11.1K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.4K
Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.4K

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Background:

  • Rising prevalence of pediatric obesity and associated complications.
  • Need for early intervention to prevent chronic diseases in children.
  • Metabolic syndrome poses a significant health risk in pediatric populations.

Purpose of the Study:

  • To provide a comprehensive overview of pediatric metabolic syndrome.
  • To discuss current pediatric metabolic syndrome guidelines.
  • To highlight clinical practice implications for managing this condition.

Main Methods:

  • Literature review of pediatric metabolic syndrome.
  • Analysis of current clinical practice guidelines.
  • Synthesis of information on pathophysiology and risk factors.

Main Results:

  • Detailed explanation of metabolic syndrome in children.
  • Summary of established pediatric metabolic syndrome guidelines.
  • Identification of key risk factors and their impact.

Conclusions:

  • Effective management of pediatric metabolic syndrome is crucial for preventing long-term health issues.
  • Adherence to guidelines and understanding risk factors are essential for clinicians.
  • Early intervention strategies can mitigate the complications of metabolic syndrome in children.